Androgen receptor activity in T cells limits checkpoint blockade efficacy
Nature, Published online: 23 March 2022; doi:10.1038/s41586-022-04522-6
. Androgen-receptor blockade can overcome immunotherapy resistance in prostate cancer by intrinsically enhancing T cell function and IFNγ responses.
Comments
Post a Comment